Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients

Brazilian Journal of Medical and Biological Research

Volumn 42, Issue 3, 2009, Pages 289-293

  Garnica, M ^a   Maiolino, A ^a   Nucci, M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antibiotic resistance; Gram negative bacteria; Hematopoietic stem cell transplant; Neutropenia; Risk factors

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CORTICOSTEROID; IMIPENEM; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; GRAFT RECIPIENT; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MORTALITY; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; UNIVARIATE ANALYSIS;

BACILLI (CLASS); BURKHOLDERIA; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS;

EID: 65549085654     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009000300010     Document Type: Article

References (17)

1. Picazo JJ. Management of the febrile neutropenic patient: a consensus conference. Clin Infect Dis 2004; 39 (Suppl 1): S1-S6.
2. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006; 42 (Suppl 2): S82-S89.
3. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 2004; 39 (Suppl 1): S25-S31.
4. Collin BA, Leather HL, Wingard JR, Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33: 947-953.
5. Cordonnier C, Herbrecht R, Buzyn A, Leverger G, Leclercq R, Nitenberg G, et al. Risk factors for Gram-negative bacterial infections in febrile neutropenia. Haematologica 2005; 90: 1102-1109.
6. Lark RL, McNeil SA, VanderHyde K, Noorani Z, Uberti J, Chenoweth C. Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis 2001; 33: 338-343.
7. From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. J Infect Dis 1990; 161: 397-401.
8. Fluit AC, Schmitz FJ, Verhoef J. Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens. Int J Antimicrob Agents 2001; 18: 147-160.
9. Labarca JA, Leber AL, Kern VL, Territo MC, Brankovic LE, Bruckner DA, et al. Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis 2000; 30: 195-197.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th edn. 2006.
11. Ohmagari N, Hanna H, Graviss L, Hackett B, Perego C, Gonzalez V, et al. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 2005; 104: 205-212.
12. Krcméry V Jr, Spanik S, Krupova I, Trupl J, Kunova A, Smid M, et al. Bacteremia due to multiresistant Gram-negative bacilli in neutropenic cancer patients: a case controlled study. J Chemother 1998; 10: 320-325.
13. Krcmery V Jr, Trupl J, Kunova A, Spanik S, Ilavska I, Hel'pianska L, et al. Imipenem-resistant P. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Bratisl Lek Listy 1996; 97: 647-651.
14. Howard DH, Scott RD, Packard R, Jones D. The global impact of drug resistance. Clin Infect Dis 2003; 36: S4-S10.
15. Howard DH, Scott RD. The economic burden of drug resistance. Clin Infect Dis 2005; 41 (Suppl 4): S283-S286.
16. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med 2005; 165: 1375-1380.
17. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections caused by antibiotic-resistant Gramnegative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760-766.